The Catalan biotech company Vytrus Biotech, specializing in active ingredients for cosmetics developed through plant biotechnology, has announced an ambitious expansion plan. According to a statement sent to the market along with reports collected by La Vanguardia, it will invest up to 5.5 million euros to build a new production and logistics plant in Terrassa (Barcelona).
Objective and dimensions of the project
The first phase includes an investment of approximately 3.5 million euros between November 2025 and the end of 2026 to enable an industrial building of about 1,600 m². Thanks to this expansion, the company estimates it can triple its current production capacity. In a second phase, which will depend on the evolution of the business, there are plans to expand the capacity by up to five times.
The contract signed for this expansion is a long-term lease (15 years) and stipulates that the current headquarters, which includes R&D&I, offices and corporate services, will remain on Sant Gaietà street in Terrassa, while the new plant will be in another nearby building, adding up to a total of about 3,000 m² of facilities.
Vytrus Biotech explains that this industrial deployment responds to the acceleration in demand for natural active ingredients for cosmetics and the need to be prepared to serve large international clients who require high industrial capacities and tighter delivery times.
The project is also part of its 2024-2027 Strategic Plan, seeking to consolidate its position as an international benchmark in biotechnology applied to beauty, with an approach that combines innovation, sustainability, and scalability.
In the first six months of 2025, Vytrus recorded a 75% growth in sales compared to the same period in 2024, reaching 4.38 million euros, while its EBITDA grew by 111% to 2.09 million euros. By region, sales increased by 76% in the EU, 49% in the US, 154% in Asia-Pacific (led by India), and 48% in LATAM. The company is already present in 47 countries across five continents.
The products that drove this growth were mainly anti-aging, hair care, and "brightening" effect products, as well as those incorporating "Exosomic Peptides" technology.